Vimarsana
Biggest News Aggregation in the World

Page 8 - Project Bioshield News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Project Bioshield. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Project Bioshield Today - Breaking & Trending Today

HyBryte™ Expanded Treatment Trial in Cutaneous T-Cell Lymphoma Opens Enrollment - Vimarsana News

HyBryte™ Expanded Treatment Trial in Cutaneous T-Cell Lymphoma Opens Enrollment

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Soligenix Announces Expansion of SGX302 (Synthetic Hypericin) Phase 2a Study in Mild-to-Moderate Psoriasis - Vimarsana News

Soligenix Announces Expansion of SGX302 (Synthetic Hypericin) Phase 2a Study in Mild-to-Moderate Psoriasis

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Public Health And Disaster Response Task Force Sends FY24 Appropriations Letter to Congress - Vimarsana News

Public Health And Disaster Response Task Force Sends FY24 Appropriations Letter to Congress

On behalf of the nation’s Governors, we write to express NGA’s continued support of state flexibility to administer federal programs with funding sufficient to meet program goals.

Source: nga.org
The Homeland Security Budget Request for FY 2005: Assessments and Proposals - Vimarsana News

The Homeland Security Budget Request for FY 2005: Assessments and Proposals

The Bush Administration's FY 2005 budget proposal calls for $47.4billion in homeland security funding: approximately 13 percent morethan estimated FY 2004 spending and a significant and appropriategrowth in homeland security expenditures. Most important, theAdministration's funding priorities dovetail well with the criticalmission areas established in the national homeland securitystrategy.

Soligenix Announces European Patent Grant for Use of Dusquetide in Oral Mucositis - Vimarsana News

Soligenix Announces European Patent Grant for Use of Dusquetide in Oral Mucositis

Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16, 2023 /PRNewswire/ -- Soligenix, Inc. , a late-stage biopharmaceutical... | May 16, 2023